Del Mar Pharmaceuticals Inc. filed its 8-K on Jan 31, 2013 for the period ending Dec 31, 2011. In this report its auditor, PricewaterhouseCoopers LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.286 USD | +0.53% | +3.66% | +68.63% |
1st Jan change | Capi. | |
---|---|---|
+68.63% | 15.73M | |
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- KTRA Stock
- News Kintara Therapeutics, Inc.
- Del Mar Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt